PBSV
Pharma-Bio Serv, Inc.
$0.57
+0.00 (+0.00%)
At close · Jul 8
Market Cap
$12.94M
Shares
22,901,692
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$9M
-5.3%
FY2025
Net Income
-$100.46K
+87.1%
FY2025
Gross Margin
32.33%
+5.9pp
FY2025
Operating Margin
-7.08%
+6.5pp
FY2025
Diluted EPS
-$0.00
+88.2%
FY2025
Operating Cash Flow
-$214.89K
+62.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $9.11M | $9M | $9.51M | $16.98M | $19.4M | $20.12M | $21.56M | $19.51M | $17.8M | $13.3M | — | — | — | — | — | — | — | |
| $6.16M | $6.09M | $6.99M | $11.91M | $14.52M | $14.76M | $14.9M | $13.33M | $12.11M | $9.46M | — | — | — | — | — | — | — | |
| $2.95M | $2.91M | $2.52M | $5.07M | $4.88M | $5.36M | $6.67M | $6.18M | $5.69M | $3.84M | $5.78M | $7.48M | $8.97M | $11.83M | $9.87M | $6.86M | $3.39M | |
| — | 32.33% | 26.46% | 29.84% | 25.16% | 26.65% | 30.92% | 31.66% | 31.95% | 28.89% | — | — | — | — | — | — | — | |
| $3.34M | $3.55M | $3.8M | $3.95M | $3.71M | $9.21M | $4.44M | $4.48M | $4.6M | $4.66M | $5.87M | $5.7M | $6.11M | $5.76M | $4.14M | $3.41M | $2.78M | |
| $60K | $59.87K | $23.31K | $48.09K | $51.11K | $72.73K | $86.28K | $99.1K | $74.6K | $107.68K | $312.56K | $357.46K | $377.2K | $344.52K | $321.73K | $320.86K | $321.71K | |
| -$397.01K | -$637.66K | -$1.29M | $1.12M | $1.17M | -$3.85M | $2.23M | $1.7M | -$1.26M | -$777.82K | -$91.76K | $1.78M | $2.86M | $6.07M | $5.73M | $3.45M | $609.89K | |
| — | -7.08% | -13.54% | 6.58% | 6.06% | -19.16% | 10.32% | 8.7% | -7.09% | -5.85% | — | — | — | — | — | — | — | |
| -$337.01K | -$577.8K | -$1.26M | $1.17M | $1.23M | -$3.78M | $2.31M | $1.8M | -$1.19M | -$670.14K | $220.8K | $2.14M | $3.24M | $6.42M | $6.06M | $3.77M | $931.6K | |
| — | — | — | — | — | — | — | — | — | — | — | $7344 | $7186 | $7213 | $7425 | $6605 | $5605 | |
| — | $37.53K | $245.82K | $320.08K | $0 | — | — | — | — | — | — | $18.81K | $5352 | $10.33K | $11.08K | $19.71K | $14.98K | |
| $468.08K | $543.4K | $532.14K | $570.08K | $13.42K | $1.98M | $64.46K | $526.57K | $435.53K | $43.75K | -$56.98K | $11.46K | $14.02K | $4596 | $22K | $11.78K | $11.3K | |
| $71.07K | -$94.26K | -$755.45K | $1.69M | $1.19M | -$1.88M | $2.29M | $2.22M | $1.52M | -$773.95K | -$203.74K | $1.79M | $2.88M | $6.08M | $5.76M | $3.46M | $621.19K | |
| $9574 | $6203 | $22.17K | $377.31K | $181.68K | $213.25K | $239.09K | $135.99K | $2.79M | $3866 | $52.83K | $167.98K | $464.53K | $1.17M | $1.07M | $304.8K | $249.28K | |
| $61.49K | -$100.46K | -$777.62K | $1.31M | $1.01M | -$2.09M | $2.05M | $2.09M | $1.28M | -$1.41M | -$256.58K | $1.62M | $2.41M | $4.91M | $4.69M | $3.16M | $371.91K | |
| — | -1.12% | -8.18% | 7.72% | 5.19% | -10.39% | 9.51% | 10.7% | 7.19% | -10.64% | — | — | — | — | — | — | — | |
| $33.51K | -$84.8K | -$725.51K | $1.28M | $1.1M | -$2.11M | $2.07M | $2.12M | $1.25M | -$1.11M | -$195.91K | $1.53M | $2.35M | $4.92M | $4.62M | $3.16M | — | |
| USD/shares | — | — | — | — | — | — | — | — | — | -$0.06 | -$0.01 | $0.07 | $0.11 | $0.22 | $0.23 | $0.15 | $0.02 |
| USD/shares | — | -$0.00 | -$0.03 | $0.06 | — | — | — | — | — | -$0.06 | -$0.01 | $0.07 | $0.10 | $0.21 | $0.20 | $0.14 | $0.02 |
| shares | — | 22.95M | 22.97M | 22.97M | 23M | 23.03M | 23M | 23.05M | 23.08M | 23.1M | 23.02M | 23.07M | 22.98M | 22.2M | 20.76M | 20.75M | 20.75M |
| shares | — | 22.96M | 22.97M | 23M | 23.03M | 23.16M | 23.04M | 23.11M | 23.1M | 23.1M | 23.19M | 23.4M | 23.69M | 23.66M | 22.94M | 22.55M | 22.38M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2025: $579.29K in buybacks, $12.07M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
188.33×
Health Information Services median 32.09×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 |
|---|---|---|---|---|---|---|
| Puerto Rico Consulting | $4,636,857 | $5,690,166 | $8,038,143 | $12,142,278 | $14,680,665 | $18,214,656 |
| United States Consulting | $2,620,430 | $3,162,151 | $4,672,255 | $4,558,018 | $2,720,662 | $2,283,370 |
| Europe Consulting | $1,727,139 | $571,183 | $4,260,224 | $2,650,783 | $2,329,359 | $829,170 |
| Other Segment | $16,670 | $85,779 | $6,234 | $47,648 | $384,489 | $237,164 |